Drug Trial Radar · NCT06394830
Safety, Efficacy, and Frequency of Administration of VNX001 in the Treatment of Interstitial Cystitis / Bladder Pain Syndrome (IC/BPS)
Last checked: Nov 19, 2026Latest source record: Jan 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
50
Planned (sponsor's estimate)
Start
Dec 13, 2024
Primary completion
Jun 2026
Study completion Jun 2026
Sponsor
- Lead sponsor
- Vaneltix Pharma, Inc.Industry
- Sponsor type
- Industry
- Collaborators
- Prevail Infoworks
- First posted
- May 1, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is an open-label study that will enroll participants with Interstitial Cystitis / Bladder Pain Syndrome (IC/BPS). The study will assess PRN (as needed) dosing of up to 6 intravesical (via catheter) doses of VNX001 (study drug) to treat acute instances of moderate to severe bladder pain over a 14-day period. The main aim of the study is to tally the number of doses and assess pain before and after doses. The study will review the safety and tolerability of VNX001. Participants will need to attend up to seven (7) clinic visits (1 for screening and up to 6 visits for VNX001 dosing) or at least one (1) clinic visit (for a combined screening/dosing visit) and 5 telephone visits over the course of 14 days. Participants will also be asked complete a diary or telephone call each day of the study, in order to record bladder pain, urinary urgency, side effects, and medications taken.
Conditions
- Interstitial Cystitis
- Bladder Pain Syndrome
Interventions
VNX001Drug
Intravesical administration of VNX001
Primary outcomes
What the sponsor says the trial is designed to measure.
- Frequency of PRN intravesical administrations of VNX001Time frame: 14 Days
Locations
5 sites in 1 country. Site status is shown where the registry gives one.
Arizona Urology Specialists
Tucson, Arizona · Completed
Valley Urology, Inc.
Fresno, California · Suspended
Prestige Medical Group
Tustin, California · Suspended
Georgia Urology
Cartersville, Georgia · Recruiting
Oregon Urology Institute
Springfield, Oregon · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.